Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dougados

Showing results (271-280 of 362) with videos related to

Pageof 37
Sort By:
Annals of the Rheumatic Diseases|October 9, 2007
Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapyM C Genovese, M Schiff, M Luggen, et al.
Rheumatology (Oxford, England)|March 11, 2005
Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectivesA Spoorenberg, A van Tubergen, R Landewé, et al.
Annals of the Rheumatic Diseases|February 21, 2003
Comparison of statistically derived ASAS improvement criteria for ankylosing spondylitis with clinically relevant improvement according to an expert panelA van Tubergen, D van der Heijde, J Anderson, et al.
Arthritis and Rheumatism|June 1, 1995
Comparative prospective, double-blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of Paget's disease of boneC Roux, C Gennari, J Farrerons, et al.
Osteoarthritis and Cartilage|April 20, 2004
OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisitedT Pham, D van der Heijde, R D Altman, et al.
Arthritis and Rheumatism|May 1, 1995
Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled studyM Dougados, S vam der Linden, M Leirisalo-Repo, et al.
The Journal of Rheumatology|May 6, 1999
Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitisA Spoorenberg, D van der Heijde, E de Klerk, et al.
Annals of the Rheumatic Diseases|June 23, 2004
Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvementF Tubach, P Ravaud, G Baron, et al.
Annals of the Rheumatic Diseases|May 8, 2004
Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom stateF Tubach, P Ravaud, G Baron, et al.
The Journal of Rheumatology|May 6, 1999
A comparative study of the usefulness of the Bath Ankylosing Spondylitis Functional Index and the Dougados Functional Index in the assessment of ankylosing spondylitisA Spoorenberg, D van der Heijde, E de Klerk, et al.
Pageof 37

Showing results (271-280 of 362) with videos related to

Sort By:
Pageof 37
Annals of the Rheumatic Diseases|October 9, 2007
Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapyM C Genovese, M Schiff, M Luggen, et al.
Rheumatology (Oxford, England)|March 11, 2005
Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectivesA Spoorenberg, A van Tubergen, R Landewé, et al.
Annals of the Rheumatic Diseases|February 21, 2003
Comparison of statistically derived ASAS improvement criteria for ankylosing spondylitis with clinically relevant improvement according to an expert panelA van Tubergen, D van der Heijde, J Anderson, et al.
Arthritis and Rheumatism|June 1, 1995
Comparative prospective, double-blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of Paget's disease of boneC Roux, C Gennari, J Farrerons, et al.
Osteoarthritis and Cartilage|April 20, 2004
OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisitedT Pham, D van der Heijde, R D Altman, et al.
Arthritis and Rheumatism|May 1, 1995
Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled studyM Dougados, S vam der Linden, M Leirisalo-Repo, et al.
The Journal of Rheumatology|May 6, 1999
Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitisA Spoorenberg, D van der Heijde, E de Klerk, et al.
Annals of the Rheumatic Diseases|June 23, 2004
Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvementF Tubach, P Ravaud, G Baron, et al.
Annals of the Rheumatic Diseases|May 8, 2004
Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom stateF Tubach, P Ravaud, G Baron, et al.
The Journal of Rheumatology|May 6, 1999
A comparative study of the usefulness of the Bath Ankylosing Spondylitis Functional Index and the Dougados Functional Index in the assessment of ankylosing spondylitisA Spoorenberg, D van der Heijde, E de Klerk, et al.
Pageof 37